NasdaqGS - Nasdaq Real Time Price USD

Maravai LifeSciences Holdings, Inc. (MRVI)

Compare
8.31 +0.02 (+0.24%)
As of 9:30 AM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
278,585.00
288,945.00
883,001.00
799,240.00
284,098.00
--
Cost of Revenue
148,400.00
148,743.00
168,957.00
140,561.00
79,649.00
--
Gross Profit
130,185.00
140,202.00
714,044.00
658,679.00
204,449.00
--
Operating Expense
178,040.00
168,670.00
147,628.00
115,283.00
103,549.00
--
Operating Income
-47,855.00
-28,468.00
566,416.00
543,396.00
100,900.00
--
Net Non Operating Interest Income Expense
-20,653.00
-18,165.00
-18,076.00
-30,260.00
-30,740.00
--
Other Income Expense
664,795.00
664,369.00
3,132.00
17,629.00
11,536.00
--
Pretax Income
596,287.00
617,736.00
551,472.00
530,765.00
81,696.00
--
Tax Provision
758,543.00
756,111.00
60,809.00
61,515.00
2,880.00
--
Net Income Common Stockholders
-132,084.00
-119,029.00
220,205.00
182,037.00
76,888.00
--
Average Dilution Earnings
--
--
206,071.00
220,319.00
-8,802.00
--
Diluted NI Available to Com Stockholders
-132,084.00
-119,029.00
426,276.00
402,356.00
68,086.00
--
Basic EPS
-1.00
-0.90
1.67
1.59
7.43
--
Diluted EPS
-1.00
-0.90
1.67
1.56
2.36
--
Basic Average Shares
133,062.00
131,919.00
131,545.00
114,791.00
10,351.14
--
Diluted Average Shares
133,062.00
131,919.00
255,323.00
257,803.00
28,907.98
--
Total Operating Income as Reported
-50,940.00
-31,648.00
574,216.00
554,645.00
119,902.00
--
Total Expenses
326,440.00
317,413.00
316,585.00
255,844.00
183,198.00
--
Net Income from Continuing & Discontinued Operation
-132,084.00
-119,029.00
220,205.00
182,037.00
76,888.00
--
Normalized Income
-129,646.85
-644,936.74
217,098.90
166,697.84
66,801.56
--
Interest Income
29,187.00
27,727.00
2,338.00
--
--
--
Interest Expense
49,840.00
45,892.00
20,414.00
30,260.00
30,740.00
--
Net Interest Income
-20,653.00
-18,165.00
-18,076.00
-30,260.00
-30,740.00
--
EBIT
646,127.00
663,628.00
571,886.00
561,025.00
112,436.00
--
EBITDA
700,503.00
712,409.00
609,989.00
594,569.00
138,273.00
--
Reconciled Cost of Revenue
148,400.00
148,743.00
168,957.00
140,561.00
79,649.00
--
Reconciled Depreciation
54,376.00
48,781.00
38,103.00
33,544.00
25,837.00
--
Net Income from Continuing Operation Net Minority Interest
-132,084.00
-119,029.00
220,205.00
182,037.00
76,888.00
--
Total Unusual Items Excluding Goodwill
-3,085.00
665,706.00
3,490.00
17,350.00
11,410.00
--
Total Unusual Items
-3,085.00
665,706.00
3,490.00
17,350.00
11,410.00
--
Normalized EBITDA
703,588.00
46,703.00
606,499.00
577,219.00
126,863.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-647.85
139,798.26
383.90
2,010.84
1,323.56
--
12/31/2019 - 11/20/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers